ABSTRACT
BACKGROUND: Data supporting a link between frailty and risk of falls is mostly confined to individuals living in urban centers, where risk factors and lifestyles are different from that of rural settings. OBJECTIVE: To assess the association between frailty and risk of falls in older adults living in rural Ecuador. DESIGN: Population-based cross-sectional study. PARTICIPANTS: Community-dwellers aged ≥60 years living in a rural Ecuadorian village, in whom frail status and risk of falls were assessed. MEASUREMENTS: Frailty was evaluated by the Edmonton Frailty Scale (EFS) and risk of falls by the Downton Fall Risk Index (DFRI). Multivariate models were fitted to evaluate whether frailty was associated with risk of falls (dependent variable), after adjusting for demographics, alcohol intake, cardiovascular risk factors, sleep quality, symptoms of depression, and history of an overt stroke. Correlation coefficients were constructed to assess confounders modifying this association. RESULTS: A total of 324 participants (mean age: 70.5±8 years) were included. The mean EFS score was 4.4±2.5 points, with 180 (56%) participants classified as robust, 76 (23%) as pre-frail and 68 (21%) as frail. The DFRI was positive in 87 (27%) participants. In univariate analysis, the EFS score was higher among participants with a positive DFRI (p<0.001). The number of frail individuals was higher (p<0.001), while that of robust individuals was lower (p<0.001) among those with a positive DFRI. Adjusted logistic regression models showed no association between frailty and the DFRI. Correlation coefficients showed that age, high glucose levels, and history of an overt stroke tempered the association between frailty and the risk of falls found in univariate analyses. CONCLUSIONS: Frailty is not independently associated with risk of falls in older adults living in a remote rural setting. Further studies are needed to assess the impact of frailty on the risk of falls in these populations.
Subject(s)
Accidental Falls/statistics & numerical data , Frail Elderly/statistics & numerical data , Frailty/epidemiology , Independent Living/statistics & numerical data , Rural Population/statistics & numerical data , Aged , Cross-Sectional Studies , Ecuador/epidemiology , Humans , Middle Aged , Risk AssessmentSubject(s)
Stroke/diagnosis , Surveys and Questionnaires , Translations , Case-Control Studies , Culturally Competent Care , Female , Humans , Male , Observer Variation , SpainABSTRACT
RESUMEN Antecedentes: La comunidad ecuatoriana es la tercera comunidad extranjera más numerosa en España. Sin embargo, es poco lo que se conoce acerca de su estado de salud cardiovascular (CV) y si los efectos de la migración han causado un detrimento en dicho estado. Métodos: Con el objetivo de conocer la salud CV en una población ecuatoriana de migrantes en Madrid, se realizó un estudio transversal no aleatorizado en el que se incluyeron personas de nacionalidad ecuatoriana, mayores de 25 años, residentes en Madrid desde hace un año o más. Se realizaron encuestas, mediante el uso de cuestionarios previamente validados, para determinar el estado de salud CV de la población, así como el grado de distress psicológico. Resultados: Se incluyeron 165 participantes (68,5% mujeres), con edad promedio de 49 años. El 86,1% de la población estudiada presentó salud cardiovascular pobre y 13,9% intermedia, sin diferencias significativas según el sexo. No hubo individuos que cumplan las 7 variables con valores ideales. Las mujeres presentaron puntuaciones más altas en el cuestionario DASS-21 en comparación a los hombres (p<0,05). Conclusión: En la población migrante ecuatoriana residente en Madrid, más del 85% presentó una salud CV pobre, y ninguno presentó una salud CV ideal. Los factores de riesgo más prevalentes en dicha población fueron pobre actividad física, sobrepeso/obesidad y malos hábitos dietéticos. Se requieren más estudios para identificar la situación real de riesgo CV de la población migrante ecuatoriana. Probablemente, a medio-largo plazo, será necesario implementar políticas de salud especialmente dirigidas a los migrantes.
ABSTRACT Background: The Ecuadorian community is the third largest foreign community in Spain. However, little is known about their cardiovascular (CV) health status and whether the effects of migration have caused a detriment in that state. Methods: With the aim of knowing the CV health in an Ecuadorian population of migrants in Madrid, a non-randomized, cross-sectional study was carried out, which included people of Ecuadorian nationality, older than 25 years, living in Madrid for a year or more. Surveys were conducted through the use of previously validated questionnaires, to determine the health status of the population, as well as the degree of neuro-physiological distress. Results: We included 165 participants (68.5% women), with an average age of 49 years. Of these, 86.1% presented poor cardiovascular health and 13.9% intermediate, without significant differences according to sex. There were no individuals that met the 7 variables consistent with and ideal CV status. Women had higher scores on the DASS-21 questionnaire compared to men (p <0.05). Conclusion: In the Ecuadorian migrant population living in Madrid, more than 85% had poor CV health, and none had an ideal CV health. Most prevalent risk factors in this population were poor physical activity, overweight/obesity and poor dietary habits. More studies are required to identify the real situation of CV risk in the Ecuadorian migrant population. Probably, in the medium-long term, it will be necessary to implement health policies especially addressed to migrants.
Subject(s)
Diet , Fish Oils/administration & dosage , Fishes , Peripheral Arterial Disease/prevention & control , Rural Health , Vascular Stiffness , Age Factors , Aged , Animals , Cross-Sectional Studies , Ecuador/epidemiology , Female , Humans , Male , Middle Aged , Nutritive Value , Peripheral Arterial Disease/diagnosis , Peripheral Arterial Disease/epidemiology , Peripheral Arterial Disease/physiopathology , Portion Size , Protective Factors , Recommended Dietary Allowances , Risk FactorsABSTRACT
BACKGROUND: A unified set of criteria for neurocysticercosis (NCC) has helped to standardize its diagnosis in different settings. METHODS: Cysticercosis experts were convened to update current diagnostic criteria for NCC according to two principles: neuroimaging studies are essential for diagnosis, and all other information provides indirect evidence favoring the diagnosis. Recent diagnostic advances were incorporated to this revised set. RESULTS: This revised set is structured in absolute, neuroimaging and clinical/exposure criteria. Absolute criteria include: histological confirmation of parasites, evidence of subretinal cysts, and demonstration of the scolex within a cyst. Neuroimaging criteria are categorized as major (cystic lesions without scolex, enhancing lesions, multilobulated cysts, and calcifications), confirmative (resolution of cysts after cysticidal drug therapy, spontaneous resolution of single enhancing lesions, and migrating ventricular cysts on sequential neuroimaging studies) and minor (hydrocephalus and leptomeningeal enhancement). Clinical/exposure criteria include: detection of anticysticercal antibodies or cysticercal antigens by well-standardized tests, systemic cysticercosis, evidence of a household Taenia carrier, suggestive clinical manifestations, and residency in endemic areas. Besides patients having absolute criteria, definitive diagnosis can be made in those having two major neuroimaging criteria (or one major plus one confirmative criteria) plus exposure. For patients presenting with one major and one minor neuroimaging criteria plus exposure, definitive diagnosis of NCC requires the exclusion of confounding pathologies. Probable diagnosis is reserved for individuals presenting with one neuroimaging criteria plus strong evidence of exposure. CONCLUSIONS: This revised set of diagnostic criteria provides simpler definitions and may facilitate its more uniform and widespread applicability in different scenarios.
Subject(s)
Neurocysticercosis/diagnosis , Brain/diagnostic imaging , Humans , NeuroimagingABSTRACT
Snake bite envenoming is a neglected tropical disease affecting millions of people living in the developing world. According to the offending snake species, the clinical picture may be dominated by swelling and soft tissue necrosis in the bitten limb, or by systemic or neurological manifestations. Serious neurological complications, including stroke and muscle paralysis, are related to the toxic effects of the venom, which contains a complex mixture of toxins affecting the coagulation cascade, the neuromuscular transmission, or both. Metalloproteinases, serine proteases, and C-type lentins (common in viper and colubrid venoms) have anticoagulant or procoagulant activity and may be either agonists or antagonists of platelet aggregation; as a result, ischemic or hemorrhagic strokes may occur. In contrast, the venom of elapids is rich in phospholipase A(2) and three-finger proteins, which are potent neurotoxins affecting the neuromuscular transmission at either presynaptic or post-synaptic levels. Presynaptic-acting neurotoxins (called ß-neurotoxins) inhibit the release of acetylcholine, while post-synaptic-acting neurotoxins (called α-neurotoxins) cause a reversible blockage of acetylcholine receptors. Proper management of the envenomed patient, including prompt transport to the hospital, correction of the hemostatic disorder, ventilatory support, and administration of antivenom, significantly reduces the risk of neurological complications which, in turn, reduce the mortality and improve the functional outcome of survivors.
Subject(s)
Nervous System Diseases/etiology , Neurotoxins/toxicity , Snake Bites/complications , Snake Bites/therapy , Snake Venoms/toxicity , Snakes , Animals , Blood Coagulation/drug effects , Humans , Snake Bites/epidemiologyABSTRACT
Here we put forward a roadmap that summarizes important questions that need to be answered to determine more effective and safer treatments. A key concept in management of neurocysticercosis is the understanding that infection and disease due to neurocysticercosis are variable and thus different clinical approaches and treatments are required. Despite recent advances, treatments remain either suboptimal or based on poorly controlled or anecdotal experience. A better understanding of basic pathophysiologic mechanisms including parasite survival and evolution, nature of the inflammatory response, and the genesis of seizures, epilepsy, and mechanisms of anthelmintic action should lead to improved therapies.
Subject(s)
Anticonvulsants/therapeutic use , Antiplatyhelmintic Agents/therapeutic use , Biomedical Research/trends , Neurocysticercosis/diagnosis , Neurocysticercosis/therapy , Neurosurgical Procedures/methods , Practice Patterns, Physicians'/trends , Forecasting , Humans , Needs Assessment , Practice Guidelines as TopicABSTRACT
Cysticercosis occurs when humans become intermediate hosts of Taenia solium after ingesting its eggs. It is the most common helminthic infection of the nervous system, and is endemic in Latin America, Asia and Africa, as well as in industrialized nations with a high immigrant influx of people coming from endemic areas. Neurocysticercosis is a pleomorphic disease due to individual differences in the number and location of the parasites within the nervous system as well as to differences in the severity of the host's immune reaction against the parasite. Common clinical manifestations include epilepsy, focal neurological signs, intracranial hypertension, and cognitive decline. Diagnosis require proper interpretation of clinical, neuroimaging, and serologic data, in the correct epidemiological context. Neuroimaging studies show the parasites as well as the changes they induce in the nervous system. Tests developed to detect anticysticercal antibodies in serum or cerebrospinal fluid present problems inherent to lack of specificity or sensibility, and should not be used by themselves to confirm or exclude the diagnosis. Cysticidal drugs (albendazole and praziquantel) have improved the prognosis of this condition. However, some patients have torpid clinical courses despite therapy. Surgery plays an important role in the management of some forms of the disease, particularly hydrocephalus and intraventricular cysts.
Subject(s)
Neurocysticercosis/diagnosis , Neurocysticercosis/therapy , Albendazole/therapeutic use , Animals , Anthelmintics/therapeutic use , Antibodies/blood , Antibodies/cerebrospinal fluid , Humans , Neurocysticercosis/pathology , Neurocysticercosis/physiopathology , Praziquantel/therapeutic use , Taenia solium/immunology , Taenia solium/metabolismABSTRACT
The authors carried out a three-phase door-to-door survey in Atahualpa, Ecuador to assess epidemiologic and pathogenetic mechanisms of stroke. They found 10 stroke patients among 1,568 individuals aged > or =15 years (crude prevalence, 638 per 100,000). There was only one incident case (incidence, 64 per 100,000). Six of the 10 patients had hypertensive arteriolopathy (five with ischemic and one with hemorrhagic stroke). Additional work is needed to increase knowledge on stroke in developing countries.
Subject(s)
Stroke/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Alcoholism/epidemiology , Comorbidity , Diabetes Complications/epidemiology , Ecuador/epidemiology , Female , Health Surveys , Humans , Hypertension/epidemiology , Incidence , Male , Middle Aged , Pilot Projects , Predictive Value of Tests , Prevalence , Recurrence , Rural Population , Sensitivity and Specificity , Surveys and QuestionnairesABSTRACT
OBJECTIVE: To evaluate the accuracy of an screening questionnaire for stroke detection in speaking-speaking communities. PATIENTS AND METHODS: We performed a door-to-door survey in Atahualpa (a rural community in coastal Ecuador) using a modified version of the Spanish translation of the OMS questionnaire for stroke detection. Subjects suspected of having a stroke as well as a 2% sample of negative subjects were evaluated by neurologists to evaluate sensitivity, specificity, and predictive value of the questionnaire and that of each of its questions. RESULTS: We found 18 possible cases among 1,568 individuals around 15 years old. Of these, 10 were confirmed stroke patients and 8 were false-positive (crude stroke prevalence of 6.38 per 1,000). We did not find false-negative cases. Sensitivity of the questionnaire was 100%, specificity was 99.5%, positive predictive value was 0.55 and negative predictive value was 1. The accuracy of each question as well as the number of questions answered as affirmative were different between patients and false-positive cases. CONCLUSIONS: The current questionnaire is highly sensitive but its positive predictive value is poor. This causes problems in large-scale studies, as the detection of many false-positives may compromise its viability. We propose a modification of the questionnaire that will turn it more accurate.
Subject(s)
Stroke/diagnosis , Surveys and Questionnaires , Adult , Aged , Aged, 80 and over , Female , Humans , Language , Male , Middle Aged , Predictive Value of TestsABSTRACT
Neurocysticercosis is responsible for increased rates of seizures and epilepsy in endemic regions. The most common form of the disease, chronic calcific neurocysticercosis, is the end result of the host's inflammatory response to the larval cysticercus of Taenia solium. There is increasing evidence indicating that calcific cysticercosis is not clinically inactive but a cause of seizures or focal symptoms in this population. Perilesional edema is at times also present around implicated calcified foci. A better understanding of the natural history, frequency, epidemiology, and pathophysiology of calcific cysticercosis and associated disease manifestations is needed to define its importance, treatment, and prevention.
Subject(s)
Epilepsies, Partial/etiology , Neurocysticercosis/complications , Animals , Brain Edema/etiology , Brain Edema/parasitology , Calcinosis/complications , Calcinosis/parasitology , Cysticercus/isolation & purification , Cysticercus/physiology , Epilepsies, Partial/parasitology , Epilepsies, Partial/physiopathology , Food Parasitology , Humans , Latin America/epidemiology , Neurocysticercosis/epidemiology , Neurocysticercosis/parasitology , Neurocysticercosis/prevention & control , Neurocysticercosis/transmission , Taenia solium/physiologyABSTRACT
AIMS: We review the relationship between body temperature and severity of acute stroke, and evaluate published evidence about the possible neuroprotective effect of hypothermia in these patients. METHODS: In acute stroke patients, hypothermia increases oxygen consumption and metabolic demands of cerebral cells, favors liberation of oxygen radicals, glutamate, and other neurotransmisors involved in brain injury, and enhances biochemical processes leading to apoptosis. Preliminary data suggest that induced hypothermia is feasible and relatively safe in acute stroke patients; this may lead to a better outcome in terms of reduced mortality and less disabling sequelae in survivors. To enhance its possible efficacy, hypothermia should be started in the first 6 to 12 hours after the event, should be prolonged for at least 24 to 48 hours, and should be done with cooling blankets or ice pads, as antipyretics are not effective to induce hypothermia in normothermic subjects. CONCLUSIONS: Hyperthermia is deleterious in acute stroke patients and must be treated. Hypothermia should not be considered a routine procedure in these patients until its safety and efficacy has been demonstrated in large trials. Patients with induced hypothermia should be closely monitorized to reduce the risk of adverse effects related to the procedure.
Subject(s)
Body Temperature/physiology , Hypothermia, Induced , Stroke , Fever/therapy , Humans , Prognosis , Stroke/diagnosis , Stroke/pathology , Stroke/physiopathology , Stroke/therapyABSTRACT
Objetivo. Revisar las manifestaciones clínicas, diagnóstico y tratamiento de entidades responsables del desarrollo de enfermedad cerebrovascular (ECV) en regiones tropicales. Desarrollo. Entre las enfermedades tropicales que se asocian con ECV se destacan: la anemia de células falciformes, la arteritis de Takayasu, la cisticercosis, la endocarditis infecciosa, la enfermedad de Chagas, las fiebres hemorrágicas víricas, la gnatostomiasis, la leptospirosis, las mordeduras de serpiente, el paludismo cerebral, la trombosis venosa puerperal y la tuberculosis. Dichas entidades pueden producir infartos o hemorragias cerebrales y, en la mayoría de los casos, estas complicaciones se relacionan con daño vascular secundario a angeítis o se presentan como parte de una coagulopatía diseminada con sangrado en otros órganos. En algunos casos, la gravedad del compromiso neurológico no permite identificar un síndrome ictal específico y las complicaciones cerebrovasculares solamente son reconocidas mediante estudios de neuroimagen o en la autopsia. Conclusiones. Existe un grupo de enfermedades, infecciosas o no, capaces de producir infartos o hemorragias cerebrales en los trópicos. Su reconocimiento oportuno permite iniciar tratamiento específico destinado a reducir la magnitud del daño cerebral y a evitar ictus recurrentes
Subject(s)
Cerebrovascular DisordersABSTRACT
Neurocysticercosis is the most common helminthic infection of the CNS but its diagnosis remains difficult. Clinical manifestations are nonspecific, most neuroimaging findings are not pathognomonic, and some serologic tests have low sensitivity and specificity. The authors provide diagnostic criteria for neurocysticercosis based on objective clinical, imaging, immunologic, and epidemiologic data. These include four categories of criteria stratified on the basis of their diagnostic strength, including the following: 1) absolute--histologic demonstration of the parasite from biopsy of a brain or spinal cord lesion, cystic lesions showing the scolex on CT or MRI, and direct visualization of subretinal parasites by funduscopic examination; 2) major--lesions highly suggestive of neurocysticercosis on neuroimaging studies, positive serum enzyme-linked immunoelectrotransfer blot for the detection of anticysticercal antibodies, resolution of intracranial cystic lesions after therapy with albendazole or praziquantel, and spontaneous resolution of small single enhancing lesions; 3) minor--lesions compatible with neurocysticercosis on neuroimaging studies, clinical manifestations suggestive of neurocysticercosis, positive CSF enzyme-linked immunosorbent assay for detection of anticysticercal antibodies or cysticercal antigens, and cysticercosis outside the CNS; and 4) epidemiologic--evidence of a household contact with Taenia solium infection, individuals coming from or living in an area where cysticercosis is endemic, and history of frequent travel to disease-endemic areas. Interpretation of these criteria permits two degrees of diagnostic certainty: 1) definitive diagnosis, in patients who have one absolute criterion or in those who have two major plus one minor and one epidemiologic criterion; and 2) probable diagnosis, in patients who have one major plus two minor criteria, in those who have one major plus one minor and one epidemiologic criterion, and in those who have three minor plus one epidemiologic criterion.
Subject(s)
Neurocysticercosis/diagnosis , HumansABSTRACT
OBJECTIVES: To review the clinical manifestations, diagnosis, and therapy of diseases causing cerebrovascular disease (CVD) in the tropics. DEVELOPMENT: Most prevalent conditions causing CVD in the tropics include: sickle cell disease, Takayasu s arteritis, cysticercosis, infective endocarditis, Chagas disease, viral hemorrhagic fevers, gnathostomiasis, leptospirosis, snake bites, cerebral malaria, puerperal venous thrombosis, and tuberculosis. These conditions may cause cerebral infarcts or hemorrhages, and in most instances are related to either vascular damage secondary to angiitis or hemorrhagic diathesis with bleeding in other organs. In some patients, the severity of the neurological picture makes impossible to identify an specific stroke syndrome and cerebrovascular complications are only recognized on neuroimaging studies or autopsy. CONCLUSIONS: There is a group of tropical infectious and non infectious diseases that may cause cerebral infarcts or hemorrhages. Prompt diagnosis and therapy are needed to reduce the severity or brain damage and to avoid recurrent strokes.